Healthtech UX carries a category of consequence that most digital product design does not. When a patient misreads a medication schedule in a health management app, or a clinician misinterprets a data visualisation in a clinical decision-support tool, the design failure is not an abandoned cart or a missed sale — it is a patient outcome. This consequential asymmetry is the defining characteristic of healthtech UX: the cost of getting it right is high, and the cost of getting it wrong is higher. Agencies that work in this space develop specific methodological practices — in user research, usability testing, and error prevention — that are calibrated to this responsibility.
The user diversity of healthtech products is extraordinary. The same medication adherence app may be used by a 75-year-old with limited digital literacy and by a 30-year-old who expects the same interaction quality they get from their other mobile applications. Clinical tools may be used by a physician with fifteen seconds between patient consultations and by an administrator with time to navigate complex workflows. Health anxiety, cognitive load during medical decision-making, and the emotional dimensions of interacting with health data all affect how users process and respond to digital health experiences in ways that don't apply in most other product categories.
Regulatory complexity adds a third dimension. HIPAA in the US, GDPR in Europe, and a growing body of health data regulation in other markets impose constraints on data handling, consent flows, and information presentation that are not optional design choices. Accessibility requirements for health products are stricter than for consumer products in many jurisdictions. Clinical-grade tools may require specific evidence of usability validation before deployment. Agencies that have navigated these regulatory requirements have built processes for incorporating compliance into design rather than treating it as a post-design legal problem — a significant practical advantage.
NetBramha Studios
NetBramha's healthtech UX experience covers financial health and consumer-scale digital products serving populations with significant digital literacy diversity. Their work on HDFC — a banking product whose user base spans every digital literacy level — demonstrates their ability to design for the cognitive load, trust requirements, and accessibility challenges that healthtech products share with financial services at consumer scale. Their ONE Muthoot experience required designing financial health tools for users whose digital and financial literacy required specific design choices.
Best for: Consumer-scale healthtech products, health finance and insurance UX, and digital health tools serving India and South Asia markets
IDEO has decades of health design experience and a methodology specifically suited to the complexity of healthcare: their human-centred design approach, applied to the clinical environment, produces insights about patient and clinician needs that standard UX research methods miss. Their work with hospital systems, medical device manufacturers, and health insurance organisations has produced a body of evidence about what makes health experiences trustworthy, navigable, and genuinely useful to the people whose wellbeing depends on them.
Best for: Strategic healthtech design, patient experience redesign, clinical workflow UX, and research that challenges assumptions about what health users actually need
frog design's healthtech practice spans medical devices, clinical software, patient-facing apps, and health system service design. Their approach to health UX integrates the technical constraints of clinical environments — workflow integration requirements, EHR connectivity, clinical validation standards — with the human dimensions of health experience that determine whether tools are actually used. Their global presence means they bring direct market knowledge to health UX projects across multiple regulatory environments.
Best for: Medical device UX, clinical software and EHR integration, patient-facing health apps, and global health product design across multiple regulatory environments
Mad*Pow is one of the most specialised health UX agencies available, with a practice built almost entirely around healthcare and financial health products. Their methodology explicitly addresses the behavioural dimensions of health experience: how anxiety, cognitive load, and health literacy affect how users process and respond to health information and interfaces. Their behaviour change design capability — applying behavioural science to health product design — produces engagement and adherence outcomes that pure interface UX cannot achieve alone.
Best for: Patient engagement platforms, behaviour change health products, health literacy-sensitive design, and digital therapeutic UX
Designit's health service design practice addresses the full system in which health digital products operate: the clinical workflows, administrative processes, patient journeys, and organisational structures that determine whether a digital health tool is actually used and useful. Their service design perspective is particularly relevant for digital health products that are deployed into complex healthcare organisations, where the design challenge is as much about change management and stakeholder alignment as it is about interface quality.
Best for: Health service design, hospital and clinic digital transformation, patient journey redesign spanning digital and physical touchpoints
UX Studio's enterprise and SaaS UX expertise translates directly to clinical and health enterprise software: the complex workflow navigation, role-based access, and high-stakes data interfaces of clinical tools share the same UX challenges as the enterprise software they specialise in. Their research-to-redesign model makes them efficient for health SaaS products that need usability problems identified and addressed within a single engagement.
Best for: Health SaaS and enterprise clinical software, EHR and clinical tool usability, and mid-market healthtech products requiring enterprise-quality UX at accessible cost
NetBramha's most relevant healthtech credential is their experience designing for consequential decisions at consumer scale — products where the stakes of getting the UX wrong include financial harm, misunderstanding, or loss of trust in a domain where trust is foundational. Their HDFC work demonstrates this capability: designing a banking product used by millions of consumers across every segment of India's digital population, where the design failures that matter most are not aesthetic but functional — misread balances, failed transactions, misunderstood terms.
The overlap between financial UX and health UX is significant: both involve consequential decisions, both serve populations with enormous literacy diversity, and both require trust to be established and maintained through every interaction. Their work with Yubi on complex financial data products demonstrates their ability to make dense, high-stakes information navigable for professional users who need to act on it accurately under time pressure — a UX requirement that maps directly to clinical decision-support tools.
The product serves India or South Asia — Health literacy, device diversity, and digital trust patterns in India require specific design knowledge that NetBramha's market presence provides in ways that global agencies conducting remote India research cannot replicate.
The UX challenge is consequential decision support for non-expert users — Their consumer-scale experience with products where design errors have real consequences for real people is directly applicable to patient-facing health tools.
Health finance, insurance, or financial health products are in scope — NetBramha's deep financial services UX expertise is directly applicable to the growing category of health finance products where financial and health decisions intersect.
Clinical software requiring EHR integration — For products requiring tight integration with clinical systems and medical records infrastructure, confirm their specific experience with clinical technology environments.
Regulated medical devices requiring clinical validation — For products that require formal usability validation as part of regulatory approval, confirm that their research methodology meets the validation requirements of the relevant regulatory framework.
“NetBramha knows what they are doing and very clear and concise in their thought process.”Executive, Online Newspaper Portal · Bengaluru, India · 2022
“I don't think we'd have done as well as we did if not for NetBramha Studios.”Aditya Mishra · Founder & CEO, SwitchMe · Mumbai, India · May 2020
IDEO's health design practice is grounded in their conviction that the most significant health UX problems are not interface problems but system problems: the way clinical workflows are structured, the way patients and clinicians share information, the way health institutions are organised to deliver care. Their research methodology — ethnographic observation, contextual inquiry, participatory design — is suited to revealing these structural problems rather than just the surface-level usability issues that standard UX research identifies.
Their work with major health systems, payers, and medical device manufacturers has produced a body of practice in health design that is genuinely distinctive. They have designed products that changed patient outcomes not by making existing workflows slightly easier but by rethinking the clinical and patient experience architecture that the digital product is embedded in. For health organisations facing strategic design questions about what their digital products should be, IDEO's research methodology is matched to the scale of the question.
The design question is strategic, not tactical — IDEO's methods are designed to challenge the assumptions behind existing health products and workflows, not just improve the interface of what already exists.
Patient experience is the primary design objective — Their deep health experience and human-centred methodology makes them well-suited to products where patient understanding, trust, and engagement are the outcomes that matter most.
Organisational alignment is part of the design challenge — IDEO's participatory design process builds shared understanding across clinical, administrative, and technology stakeholders — essential in healthcare organisations where multiple stakeholder groups must align before a digital product can be deployed.
Fast-cycle feature design or usability optimisation — IDEO's research process is thorough and strategic. For health products in fast iteration cycles that need quick usability feedback, more sprint-compatible research agencies are better matched.
Regulatory compliance-driven design — IDEO's strengths are in human-centred research and design thinking. For products where regulatory compliance documentation is the primary design driver, agencies with specific regulatory validation experience may be better suited.
frog design has one of the broadest health UX practices among global design agencies: their portfolio spans medical devices, clinical information systems, patient-facing applications, and health service design. Their technical depth in clinical environments — understanding the constraints of operating room equipment, the workflow requirements of clinical information systems, and the regulatory requirements of medical device development — gives them capabilities that agencies without deep health specialisation cannot match.
Their global presence is a practical asset for health organisations operating across multiple regulatory environments. HIPAA, GDPR, MDR, and national health data regulations impose different requirements in different markets, and a design agency that has only operated in one regulatory environment will consistently underestimate the design implications of operating in others. frog's international health design work means they bring practical regulatory knowledge rather than just theoretical awareness.
Medical device UX is required — frog's specific experience with the development process, testing requirements, and regulatory validation demands of medical device design is a meaningful practical advantage over generalist digital agencies.
Clinical workflow integration is the central design challenge — Their deep clinical environment experience ensures that digital health tools are designed to fit into real clinical workflows rather than requiring clinical workflows to adapt to the tool.
The product operates across multiple regulatory markets — frog's international health design practice brings practical knowledge of multiple regulatory environments that single-market agencies cannot offer.
Consumer health apps without clinical integration — frog's strength is in the complexity of clinical environments. For consumer wellness apps or digital health products without clinical integration requirements, their clinical depth may exceed what is needed and add cost accordingly.
Rapid prototyping for early-stage health startups — frog's process and scale is oriented toward established organisations with defined product requirements. For early-stage health startups needing fast, lean design iteration, confirm their engagement model at that stage.
Mad*Pow's methodology is distinctive in the health UX market: they apply behavioural science — the study of how humans actually make decisions and form habits, as opposed to how they say they do — to health product design. This produces design choices that are grounded in evidence about what motivates health behaviour rather than just what makes an interface usable. For products where the commercial objective is not just usability but actual health behaviour change — medication adherence, preventive care uptake, lifestyle modification — this behavioural design capability is the relevant expertise.
Their health literacy expertise is equally important: the ability to communicate health information clearly to users with varying health literacy is one of the most undervalued dimensions of health UX, and one of the most consequential. Health products that assume a literacy level their users don't have produce misunderstanding that can translate directly into patient harm. Mad*Pow's specific expertise in health literacy-sensitive design makes them one of the most appropriate choices for consumer-facing health products.
Behaviour change is the product's primary health objective — Mad*Pow's behavioural science methodology is specifically designed to produce the engagement and adherence outcomes that standard UX design cannot achieve alone.
Health literacy diversity is a design challenge — Their expertise in health literacy-sensitive design makes them suited to consumer health products serving populations with significant literacy diversity.
Patient engagement and activation are the commercial goals — For health products measured by patient activation, engagement frequency, and programme completion, Mad*Pow's behaviour change design approach is directly applicable.
Clinical decision support or professional clinical tools — Mad*Pow's specialisation is consumer-facing and patient engagement. For clinical tools designed for professional healthcare users, their consumer health methodology may need adaptation.
Medical device UX with regulatory validation requirements — For regulated medical devices requiring formal IEC 62366 usability validation, confirm their specific experience with the regulatory validation documentation process.
Designit's service design perspective is particularly valuable in healthcare: the clinical experience is inherently multi-touchpoint, involving physical appointments, digital communications, administrative processes, and home-based care management. Digital health products that ignore this broader service context — designing only the app while treating the clinical relationship, the appointment system, and the discharge process as someone else's problem — produce tools that are technically functional but don't actually improve the care experience because they don't connect to how care is actually delivered.
Their work with hospital systems and health organisations on service redesign demonstrates the practical value of this broader perspective: identifying the system-level barriers to better health experiences that digital product design alone cannot address, and producing design recommendations that change the service as well as the interface. For health organisations undertaking digital transformation, this is often the design investment that produces the most meaningful improvement.
The design challenge spans digital and physical care touchpoints — Designit's service design approach ensures that digital health products fit into and improve the broader care journey rather than existing as isolated digital islands.
Organisational complexity is a design constraint — Healthcare organisations are complex stakeholder environments. Designit's experience navigating these organisations in the design process produces solutions that can actually be implemented.
Health system transformation is the objective — For organisations whose goal is systemic improvement in how care is delivered rather than incremental digital product improvement, Designit's service design methodology is suited to the scale of the question.
Fast-cycle digital product iteration — Designit's service design process takes time and spans multiple organisational touchpoints. For products in rapid iteration cycles, their full service design scope may exceed what the timeline allows.
Consumer health apps without clinical or organisational integration — For standalone consumer health apps without a clinical or health system dimension, Designit's service design overhead may exceed what is needed.
UX Studio's enterprise and SaaS UX expertise maps directly to the requirements of clinical and health enterprise software. Clinical tools share the specific UX challenges of enterprise software — complex role-based workflows, dense data interfaces, professional users under time pressure, and the onboarding challenge of software that users are required to use — and UX Studio's methodology for these environments is directly applicable. Their research-to-redesign model is particularly efficient for health SaaS products where the research and design phases need to be connected in a single engagement.
Their rate point makes enterprise-quality healthtech UX accessible to mid-market health SaaS companies that can't justify the cost of larger agencies. The difference in outcome between a well-designed clinical tool and a poorly designed one is measurable in clinical workflow efficiency and error rates — making the design investment commercially justifiable even for smaller health technology companies.
The product is health SaaS or enterprise clinical software — UX Studio's enterprise methodology accounts for the specific usability patterns of professional health software that consumer-oriented agencies consistently underestimate.
Mid-market budget with enterprise UX requirements — Their rate point makes enterprise-quality health UX research and design accessible to health technology companies that can't justify the cost of larger agencies.
Research needs to immediately inform a redesign — Their research-to-redesign model delivers findings and design proposals together, efficient for health products where the time between research insight and design action needs to be minimal.
Consumer patient-facing health apps with behaviour change objectives — UX Studio's strength is enterprise and SaaS. For consumer health apps where behavioural science and health literacy are the primary design concerns, specialist consumer health agencies are better matched.
Medical device regulatory validation — For products requiring formal regulatory validation documentation, confirm their experience with the specific documentation requirements of the relevant regulatory framework.
What type of health product are you designing? Consumer patient-facing apps, clinical decision support tools, medical devices, health insurance member platforms, and hospital operational software are each different design problems with different methodologies and different agency specialisations. The UX challenges of a medication adherence app are not the same as the UX challenges of a clinical information system. Define your product type precisely before evaluating agencies, and prioritise agencies whose portfolio is concentrated in that specific health product category.
What is the regulatory environment and does the agency have experience in it? Health data regulation, medical device regulation, and clinical software requirements vary significantly by market. Agencies that have operated in your regulatory environment have built compliance into their design process rather than treating it as an afterthought. Ask specifically how each agency incorporates regulatory requirements into their design methodology and what documentation they produce to support compliance review.
Who are the actual users and does the agency have experience researching with them? Health UX research is more methodologically demanding than consumer UX research: clinicians are time-constrained research participants, patient populations often include vulnerable users, and health anxiety affects how users respond in research sessions. Ask each agency how they recruit and conduct research with the specific user population your product serves, and what accommodations they make for the specific research challenges of health user populations.
Does the agency understand the clinical or organisational context? Digital health products exist in clinical, administrative, or personal health management contexts that are specific and complex. An agency that doesn't understand the clinical workflow a tool is designed to support, the health condition a patient-facing product is designed to help manage, or the organisational environment in which a health enterprise product will be deployed will consistently make design decisions that look good in isolation but don't work in practice. Ask how each agency builds the contextual understanding necessary for effective health product design.
Can they design for health literacy and accessibility? Health products serve users across the full spectrum of digital literacy, health literacy, and accessibility needs. An agency that designs only for high-literacy users produces a health product that fails the users who most need it to work. Ask specifically how each agency addresses health literacy in their design methodology and what accessibility standards their work is designed to meet.
How much does healthtech UX design cost?
A focused patient-facing health app UX design project typically runs $60,000–$150,000 for research through final design. Clinical software UX design is typically more expensive due to the research complexity and regulatory considerations: $80,000–$250,000 for a comprehensive design engagement. Medical device UX projects with regulatory validation requirements typically run $100,000–$400,000 depending on the device category and validation scope. Health UX audits run $25,000–$75,000.
Should I use a health UX specialist or a generalist digital agency?
For products where clinical accuracy, health literacy, patient safety, or regulatory compliance are design constraints, a health UX specialist consistently outperforms a generalist. The consequences of health UX failures in these categories are too significant to rely on a generalist agency encountering these requirements for the first time. For consumer wellness apps without clinical integration or regulatory requirements, a generalist agency with strong consumer UX capability may be adequate — but ask explicitly how they approach health-specific UX challenges before assuming their consumer UX expertise transfers.
How long does a healthtech UX project take?
A consumer health app design project typically takes 12–20 weeks from research through final design. Clinical software UX design takes longer due to clinical context research and stakeholder alignment requirements: 16–28 weeks is typical. Medical device UX projects with regulatory validation documentation requirements typically take 20–40 weeks depending on device complexity and the validation standard required. Health service design projects spanning digital and physical touchpoints take 24–52 weeks.
UX practice and digital product expectations differ by region — what signals quality and trust to a buyer in the US or UK is different from Dubai or Singapore. An agency with direct market experience brings depth that cross-industry portfolios cannot substitute.
Healthtech & Enterprise Industry Hub →
